Home/Filings/4/0001349929-14-000020
4//SEC Filing

CANCER GENETICS, INC 4

Accession 0001349929-14-000020

CIK 0001349929operating

Filed

Dec 14, 7:00 PM ET

Accepted

Dec 15, 6:52 PM ET

Size

5.4 KB

Accession

0001349929-14-000020

Insider Transaction Report

Form 4
Period: 2014-12-11
El Naggar Jane Houldsworth
VP of Research and Development
Transactions
  • Award

    Stock Option (right to buy)

    2014-12-11+10,00010,000 total
    Exercise: $6.30Exp: 2024-12-10Common Stock (10,000 underlying)
Footnotes (1)
  • [F1]Options vest twenty percent on the date of grant, with subsequent vesting in equal installments over the following forty-eight months.

Issuer

CANCER GENETICS, INC

CIK 0001349929

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001349929

Filing Metadata

Form type
4
Filed
Dec 14, 7:00 PM ET
Accepted
Dec 15, 6:52 PM ET
Size
5.4 KB